SNY

Regeneron Just Moved From Underperform To Buy - Here's Why

01/07 05:18 pm

FDA Flags Liver Injury Risk In Sanofi's Rejected Multiple Sclerosis Drug

01/06 09:54 am

Cytokinetics to Present at the 44th Annual J.P. Morgan Healthcare Conference

01/05 05:00 pm

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ: DVAX)

01/05 03:22 pm

Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026

12/31 09:59 am

Celiac Disease Market Report 2025-2035: Drivers, Challenges, Opportunities, Industry Trends and Case Studies

12/30 11:51 am

Stock Market Today: Records, Metals Mania and Mixed Tech Tape

12/25 02:07 am

Dynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why

12/25 01:27 am

Why Dynavax Stock Soared Today

12/24 04:35 pm

Sanofi Makes $2.2 Billion Bet On Adult Vaccines With Dynavax Buy

12/24 07:21 am

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

12/19 05:00 pm

Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies

12/17 11:00 am

Communiqué de presse : Mise en ligne du document «Q4 2025 Aide mémoire »

12/17 02:30 am

Press release: Availability of the Q4 2025 Aide memoire

12/17 02:30 am

Sanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaboration

12/15 02:10 pm

Sanofi's Multiple Sclerosis Drug Faces Trial And Regulatory Setbacks

12/15 08:52 am

Sanofi Scores Two Major China Approvals For Rare Blood Disorder Drugs

12/11 02:11 pm

Prolynx Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates and Appoints Chris Boulton as Chief Executive Officer

12/11 08:00 am

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

12/10 02:00 pm

Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks

12/09 12:30 pm

Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

12/08 02:00 pm

Antibody Discovery Market to Reach USD 17.68 Billion by 2032, Driven by Rising Demand for Targeted Therapies and Advancements in AI Powered Antibody Engineering – SNS Insider

12/07 10:26 am

Is Alnylam Pharmaceuticals a Millionaire Maker?

12/07 03:25 am

Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition

12/06 10:30 am

Communiqué de presse : Sanofi finalise l’acquisition de Vicebio

12/04 06:00 am

Press Release: Sanofi completes acquisition of Vicebio

12/04 06:00 am

Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

12/03 02:00 pm

Insulin Analog Market Forecasting USD 25.29 Billion Valuation by 2034

12/03 12:00 pm

Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

12/01 08:00 am

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?

12/01 12:15 am

Atopic Dermatitis Drugs Market to Reach $29.43 Billion by 2032, Driven by Rising Disease Prevalence & Strong Therapeutic Innovation | SNS Insider

11/28 01:28 am

Communiqué de presse : Sanofi investit 50 millions d’euros au Trait pour accélérer la production de médicaments innovants

11/27 09:00 am

CG Oncology Announces New Board Member and Board Transition

11/26 08:00 am

DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year

11/24 09:00 am

Polycystic Ovary Syndrome Treatment Market Expected to Reach USD 9.12 Bn by 2034

11/19 12:00 pm

Is Recursion Pharmaceuticals a Meme Stock?

11/19 09:13 am

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION

11/11 03:27 pm

Orphan Drug Market to Reach USD 621.85 Billion by 2034, Driven by Rising Rare Disease Incidence and Innovation

11/10 12:00 pm

Communiqué de presse : ACAAI : L’étude pivot Dupixent menée par Sanofi et Regeneron a atteint l’ensemble de ses critères d’évaluation principaux et secondaires, réduisant les signes et symptômes de la rhinosinusite fongique allergique...

11/07 09:00 am

Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

11/07 09:00 am

Pulmonary Emphysema Market Set to Expand by 2034 with Rising COPD Prevalence and Therapeutic Innovation | DelveInsight

11/03 02:00 pm

Pelvic Inflammatory Disease Treatment Market to Reach USD 5.09 Billion by 2034, Driven by Rising STI Cases and Growing Awareness

11/03 12:00 pm

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

11/03 10:00 am

Recludix Pharma to Present at Two Investor Conferences in November

11/03 09:00 am

Draig Therapeutics Appoints Seasoned Neuroscience Leader Ivana Magovčević-Liebisch as President and Chief Executive Officer

11/03 07:00 am

Medidata Unveils Next-Generation Patient Consent Innovations, Designed in Partnership with Clinicians and Patient Advocates

10/30 12:00 pm

Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness

10/28 09:13 am

UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey

10/27 08:47 pm

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark

10/24 10:47 am

Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24+ Companies and 26+ Therapies | DelveInsight

10/23 01:00 pm